ID   FDC-P1 Beta6
AC   CVCL_A0ML
SY   Beta6-FDC-P1
DR   Wikidata; Q108820236
RX   Patent=US9745376;
RX   PubMed=14960589;
CC   Genetic integration: Method=Transfection/transduction; Gene=MGI; MGI:96615; Itgb6.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
CC   Breed/subspecies: DBA/2.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2039 ! FDC-P1
CA   Factor-dependent cell line
DT   Created: 23-09-21; Last updated: 14-08-25; Version: 6
//
RX   Patent=US9745376;
RA   Violette, Shelia M.
RA   Weinreb, Paul Henry
RA   Simon, Kenneth J.
RA   Sheppard, Dean
RA   Leone, Diane R.
RT   "Anti-alphavbeta6 antibodies.";
RL   Patent number US9745376, 29-Aug-2017.
//
RX   PubMed=14960589; DOI=10.1074/jbc.M312103200;
RA   Weinreb, Paul Henry
RA   Simon, Kenneth J.
RA   Rayhorn, Paul
RA   Yang, William J.
RA   Leone, Diane R.
RA   Dolinski, Brian M.
RA   Pearse, Bradley R.
RA   Yokota, Yukako
RA   Kawakatsu, Hisaaki
RA   Atakilit, Amha
RA   Sheppard, Dean
RA   Violette, Shelia M.
RT   "Function-blocking integrin alphavbeta6 monoclonal antibodies:
RT   distinct ligand-mimetic and nonligand-mimetic classes.";
RL   J. Biol. Chem. 279:17875-17887(2004).
//